Journal of medical Internet research

Patient Views on Ozempic (Semaglutide) for Weight Loss from Online Reviews

Updated

Abstract

Two-thirds of respondents reported reduced appetite, food cravings, or body weight while using Ozempic.

  • Gastrointestinal complaints were common among users, reported by 62% of reviewers.
  • These gastrointestinal side effects did not significantly influence overall satisfaction ratings or decisions to continue treatment.
  • Minimal or no weight loss, along with the emergence of non-gastrointestinal side effects, was more frequently linked to low satisfaction and treatment discontinuation.
  • Effective weight loss, even with gastrointestinal side effects, was associated with a higher likelihood of continuing Ozempic treatment.

Simplified

Full Text

We can’t show the full text here under this license.

Funding

Competing interests

Conflicts of Interest: MHJ is an inventor on patent PCT/US23/27918 titled “Therapeutic combinations and methods,” which describes novel approaches for reducing overeating. All other authors declare no competing interests.
PubMed

What Lands in Your Inbox Each Week:

  • 📚7 fresh studies
  • 📝plain-language summaries
  • ✅direct links to original studies
  • 🏅top journal indicators
  • 📅weekly delivery
  • 🧘‍♂️always free